 Emily Downs
Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Valve Prosthesis Implantation | 7 | 2026 | 197 | 1.400 |
Why?
| | Mitral Valve | 4 | 2018 | 96 | 0.950 |
Why?
| | Fontan Procedure | 7 | 2025 | 191 | 0.910 |
Why?
| | Heart Transplantation | 3 | 2024 | 736 | 0.850 |
Why?
| | Blood Group Incompatibility | 1 | 2024 | 20 | 0.850 |
Why?
| | ABO Blood-Group System | 1 | 2024 | 57 | 0.820 |
Why?
| | Pulmonary Atresia | 1 | 2023 | 22 | 0.780 |
Why?
| | Heart Neoplasms | 1 | 2023 | 56 | 0.770 |
Why?
| | Tetralogy of Fallot | 1 | 2023 | 76 | 0.750 |
Why?
| | Heart Defects, Congenital | 5 | 2025 | 914 | 0.740 |
Why?
| | Pulmonary Valve | 1 | 2023 | 101 | 0.700 |
Why?
| | Heart Valve Prosthesis | 4 | 2026 | 134 | 0.670 |
Why?
| | Graft Rejection | 1 | 2024 | 540 | 0.660 |
Why?
| | Aorta, Thoracic | 1 | 2021 | 286 | 0.570 |
Why?
| | Cardiac Surgical Procedures | 6 | 2025 | 609 | 0.570 |
Why?
| | Hemodynamics | 6 | 2025 | 1121 | 0.550 |
Why?
| | Mitral Valve Insufficiency | 2 | 2016 | 72 | 0.550 |
Why?
| | Heart Valve Diseases | 2 | 2018 | 151 | 0.550 |
Why?
| | Heart-Assist Devices | 5 | 2020 | 567 | 0.540 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2016 | 192 | 0.530 |
Why?
| | Students, Medical | 1 | 2022 | 375 | 0.510 |
Why?
| | Cardiac Catheterization | 3 | 2026 | 560 | 0.480 |
Why?
| | Acute Kidney Injury | 2 | 2021 | 866 | 0.480 |
Why?
| | Endocardium | 1 | 2015 | 31 | 0.460 |
Why?
| | Ablation Techniques | 1 | 2015 | 36 | 0.450 |
Why?
| | Thoracoscopy | 1 | 2015 | 62 | 0.440 |
Why?
| | Cost of Illness | 1 | 2016 | 321 | 0.400 |
Why?
| | Atrial Fibrillation | 3 | 2017 | 550 | 0.390 |
Why?
| | Heart Failure | 3 | 2024 | 2323 | 0.370 |
Why?
| | Monitoring, Physiologic | 1 | 2014 | 289 | 0.370 |
Why?
| | Models, Statistical | 2 | 2016 | 682 | 0.360 |
Why?
| | Assisted Circulation | 4 | 2013 | 26 | 0.360 |
Why?
| | Models, Cardiovascular | 7 | 2015 | 195 | 0.360 |
Why?
| | Internship and Residency | 1 | 2021 | 1257 | 0.310 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 598 | 0.300 |
Why?
| | Aortic Valve Stenosis | 3 | 2017 | 253 | 0.300 |
Why?
| | Follow-Up Studies | 5 | 2025 | 5417 | 0.270 |
Why?
| | Treatment Outcome | 12 | 2026 | 11695 | 0.270 |
Why?
| | Postoperative Complications | 6 | 2025 | 2920 | 0.260 |
Why?
| | Patient Selection | 2 | 2025 | 719 | 0.260 |
Why?
| | Infant, Newborn | 3 | 2024 | 6434 | 0.250 |
Why?
| | Aortic Valve | 4 | 2018 | 365 | 0.250 |
Why?
| | Aorta, Abdominal | 2 | 2017 | 52 | 0.250 |
Why?
| | Sinus of Valsalva | 1 | 2026 | 11 | 0.240 |
Why?
| | Coronary Sinus | 1 | 2026 | 9 | 0.240 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2026 | 25 | 0.230 |
Why?
| | Humans | 33 | 2026 | 144957 | 0.230 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2026 | 46 | 0.230 |
Why?
| | Transcatheter Aortic Valve Replacement | 3 | 2017 | 152 | 0.230 |
Why?
| | Iatrogenic Disease | 1 | 2026 | 76 | 0.230 |
Why?
| | Aortic Aneurysm, Abdominal | 2 | 2017 | 167 | 0.220 |
Why?
| | Cause of Death | 2 | 2018 | 472 | 0.220 |
Why?
| | Preoperative Care | 2 | 2016 | 380 | 0.190 |
Why?
| | Vena Cava, Inferior | 3 | 2012 | 81 | 0.190 |
Why?
| | Prosthesis Design | 4 | 2026 | 357 | 0.190 |
Why?
| | Hospital Mortality | 2 | 2018 | 1031 | 0.180 |
Why?
| | Waiting Lists | 1 | 2024 | 263 | 0.180 |
Why?
| | Retrospective Studies | 10 | 2025 | 17101 | 0.180 |
Why?
| | Graft Survival | 1 | 2024 | 526 | 0.180 |
Why?
| | Catheter Ablation | 2 | 2016 | 353 | 0.170 |
Why?
| | Infant | 3 | 2025 | 10039 | 0.170 |
Why?
| | Male | 20 | 2026 | 72406 | 0.170 |
Why?
| | Computer Simulation | 4 | 2013 | 1026 | 0.170 |
Why?
| | Equipment Design | 5 | 2015 | 530 | 0.170 |
Why?
| | Ventricular Dysfunction | 1 | 2020 | 16 | 0.160 |
Why?
| | Female | 16 | 2025 | 78376 | 0.160 |
Why?
| | Pancreatic Elastase | 2 | 2017 | 55 | 0.160 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2020 | 40 | 0.160 |
Why?
| | Perfusion | 1 | 2021 | 250 | 0.160 |
Why?
| | Heart Ventricles | 2 | 2016 | 760 | 0.150 |
Why?
| | Time Factors | 4 | 2025 | 7183 | 0.150 |
Why?
| | Virginia | 2 | 2017 | 55 | 0.150 |
Why?
| | Coronary Artery Bypass | 2 | 2018 | 269 | 0.140 |
Why?
| | Middle Aged | 12 | 2025 | 35928 | 0.140 |
Why?
| | Antibodies | 2 | 2018 | 403 | 0.130 |
Why?
| | Aged | 12 | 2019 | 25947 | 0.130 |
Why?
| | Aminopropionitrile | 1 | 2017 | 3 | 0.130 |
Why?
| | Heparin | 1 | 2018 | 244 | 0.130 |
Why?
| | Thrombocytopenia | 1 | 2018 | 205 | 0.120 |
Why?
| | Aortic Aneurysm | 1 | 2017 | 70 | 0.120 |
Why?
| | Psoas Muscles | 1 | 2016 | 14 | 0.120 |
Why?
| | Lymphocyte Depletion | 1 | 2016 | 132 | 0.120 |
Why?
| | Risk Assessment | 4 | 2025 | 3676 | 0.120 |
Why?
| | Walk Test | 1 | 2016 | 80 | 0.120 |
Why?
| | Embolism | 1 | 2016 | 48 | 0.120 |
Why?
| | Education, Medical, Graduate | 1 | 2021 | 557 | 0.110 |
Why?
| | Endovascular Procedures | 1 | 2020 | 384 | 0.110 |
Why?
| | Costs and Cost Analysis | 1 | 2016 | 220 | 0.110 |
Why?
| | Risk Factors | 6 | 2025 | 10792 | 0.110 |
Why?
| | Hemorrhage | 1 | 2020 | 809 | 0.110 |
Why?
| | Sarcopenia | 1 | 2016 | 91 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2016 | 156 | 0.110 |
Why?
| | Clinical Competence | 1 | 2022 | 1244 | 0.100 |
Why?
| | Enteral Nutrition | 1 | 2016 | 216 | 0.100 |
Why?
| | Curriculum | 1 | 2021 | 1060 | 0.100 |
Why?
| | Health Care Costs | 1 | 2017 | 427 | 0.100 |
Why?
| | Mortality | 1 | 2016 | 376 | 0.100 |
Why?
| | Anticoagulants | 1 | 2018 | 724 | 0.100 |
Why?
| | Postoperative Care | 1 | 2015 | 288 | 0.100 |
Why?
| | Echocardiography | 1 | 2016 | 652 | 0.090 |
Why?
| | Quality Indicators, Health Care | 1 | 2015 | 335 | 0.090 |
Why?
| | Child, Preschool | 2 | 2025 | 11799 | 0.090 |
Why?
| | Hyperglycemia | 1 | 2016 | 375 | 0.090 |
Why?
| | Models, Anatomic | 1 | 2012 | 84 | 0.090 |
Why?
| | Ventricular Function | 1 | 2012 | 57 | 0.090 |
Why?
| | Esophageal Neoplasms | 1 | 2016 | 349 | 0.090 |
Why?
| | Survival Rate | 4 | 2018 | 2092 | 0.090 |
Why?
| | Hypoglycemia | 1 | 2016 | 477 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2018 | 741 | 0.090 |
Why?
| | Aged, 80 and over | 4 | 2016 | 8279 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2015 | 456 | 0.080 |
Why?
| | Program Evaluation | 1 | 2015 | 949 | 0.080 |
Why?
| | B-Lymphocytes | 1 | 2016 | 877 | 0.080 |
Why?
| | Patient Care Team | 1 | 2015 | 689 | 0.080 |
Why?
| | Referral and Consultation | 1 | 2015 | 853 | 0.070 |
Why?
| | Hydrodynamics | 3 | 2015 | 47 | 0.070 |
Why?
| | Critical Care | 1 | 2014 | 697 | 0.070 |
Why?
| | United States | 2 | 2025 | 15988 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2925 | 0.060 |
Why?
| | Databases, Factual | 3 | 2018 | 1486 | 0.060 |
Why?
| | Pulmonary Artery | 1 | 2012 | 1134 | 0.060 |
Why?
| | Echocardiography, Transesophageal | 1 | 2026 | 133 | 0.060 |
Why?
| | Perioperative Period | 1 | 2025 | 71 | 0.060 |
Why?
| | Stents | 2 | 2020 | 556 | 0.050 |
Why?
| | Inflammation Mediators | 2 | 2017 | 509 | 0.050 |
Why?
| | ROC Curve | 1 | 2025 | 615 | 0.050 |
Why?
| | Blood Flow Velocity | 2 | 2012 | 413 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3869 | 0.040 |
Why?
| | Age Factors | 2 | 2017 | 3335 | 0.040 |
Why?
| | Cytokines | 2 | 2017 | 2065 | 0.040 |
Why?
| | Platelet Factor 4 | 1 | 2018 | 36 | 0.040 |
Why?
| | Prognosis | 2 | 2018 | 4293 | 0.040 |
Why?
| | Direct Service Costs | 1 | 2017 | 8 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2017 | 62 | 0.030 |
Why?
| | Aortic Rupture | 1 | 2017 | 28 | 0.030 |
Why?
| | Antigens, CD20 | 1 | 2016 | 35 | 0.030 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2016 | 55 | 0.030 |
Why?
| | Hospital Costs | 1 | 2017 | 124 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2016 | 94 | 0.030 |
Why?
| | Angiotensin II | 1 | 2016 | 97 | 0.030 |
Why?
| | Biomarkers | 2 | 2018 | 4275 | 0.030 |
Why?
| | Sternotomy | 1 | 2016 | 23 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2017 | 4569 | 0.030 |
Why?
| | Benchmarking | 1 | 2017 | 188 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2016 | 246 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2016 | 94 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 5997 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 854 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 354 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2019 | 760 | 0.030 |
Why?
| | Frail Elderly | 1 | 2016 | 134 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2016 | 284 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2016 | 307 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 463 | 0.030 |
Why?
| | Esophagectomy | 1 | 2016 | 135 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 1031 | 0.030 |
Why?
| | Down-Regulation | 1 | 2016 | 627 | 0.030 |
Why?
| | Odds Ratio | 1 | 2016 | 1077 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 389 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 966 | 0.020 |
Why?
| | Nutritional Status | 1 | 2016 | 354 | 0.020 |
Why?
| | Thrombosis | 1 | 2017 | 393 | 0.020 |
Why?
| | Neoadjuvant Therapy | 1 | 2016 | 463 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2016 | 499 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1325 | 0.020 |
Why?
| | Diffusion Chambers, Culture | 1 | 2012 | 9 | 0.020 |
Why?
| | Blood Circulation | 1 | 2012 | 44 | 0.020 |
Why?
| | Hemorheology | 1 | 2012 | 24 | 0.020 |
Why?
| | Numerical Analysis, Computer-Assisted | 1 | 2012 | 18 | 0.020 |
Why?
| | Ventricular Pressure | 1 | 2012 | 52 | 0.020 |
Why?
| | Vena Cava, Superior | 1 | 2011 | 25 | 0.020 |
Why?
| | Incidence | 1 | 2018 | 2883 | 0.020 |
Why?
| | Suction | 1 | 2011 | 33 | 0.020 |
Why?
| | Pressure | 1 | 2012 | 225 | 0.020 |
Why?
| | Logistic Models | 1 | 2016 | 2119 | 0.020 |
Why?
| | Comorbidity | 1 | 2016 | 1660 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1813 | 0.020 |
Why?
| | Materials Testing | 1 | 2012 | 354 | 0.020 |
Why?
| | Sex Factors | 1 | 2016 | 2114 | 0.020 |
Why?
| | Quality Improvement | 1 | 2019 | 1291 | 0.020 |
Why?
| | Child | 2 | 2025 | 22657 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2012 | 494 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1003 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3125 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2852 | 0.020 |
Why?
| | Temperature | 1 | 2012 | 679 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 4155 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2012 | 842 | 0.020 |
Why?
| | Hypertension | 1 | 2017 | 1264 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 14126 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 3164 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1358 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2016 | 2365 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 5965 | 0.020 |
Why?
| | Adult | 2 | 2025 | 40506 | 0.020 |
Why?
| | Blood Glucose | 1 | 2016 | 2330 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2738 | 0.010 |
Why?
| | Blood Pressure | 1 | 2012 | 1769 | 0.010 |
Why?
| | Animals | 2 | 2017 | 38109 | 0.010 |
Why?
| | Adolescent | 1 | 2012 | 22453 | 0.010 |
Why?
|
|
Downs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|